

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.94043638 |
| 2 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 6.90173650 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.67604748 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 6.14532966 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.14532966 |
| 6 | inner mitochondrial membrane organization (GO:0007007) | 5.96883196 |
| 7 | respiratory electron transport chain (GO:0022904) | 5.81226517 |
| 8 | electron transport chain (GO:0022900) | 5.64444040 |
| 9 | dopamine transport (GO:0015872) | 5.48388781 |
| 10 | female mating behavior (GO:0060180) | 5.10204296 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.93439431 |
| 12 | regulation of protein kinase A signaling (GO:0010738) | 4.87829169 |
| 13 | regulation of female receptivity (GO:0045924) | 4.80270296 |
| 14 | transmission of nerve impulse (GO:0019226) | 4.51364884 |
| 15 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.42515794 |
| 16 | regulation of glutamate secretion (GO:0014048) | 4.24923912 |
| 17 | catecholamine transport (GO:0051937) | 4.11940239 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.06117197 |
| 19 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.04589258 |
| 20 | glutamate secretion (GO:0014047) | 3.91799186 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.90153652 |
| 22 | mating behavior (GO:0007617) | 3.88650002 |
| 23 | positive regulation of synapse assembly (GO:0051965) | 3.73457250 |
| 24 | protein localization to synapse (GO:0035418) | 3.73407888 |
| 25 | neuron recognition (GO:0008038) | 3.72654729 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.67293018 |
| 27 | ATP biosynthetic process (GO:0006754) | 3.66694189 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.62506664 |
| 29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.60775342 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.54995832 |
| 31 | vocalization behavior (GO:0071625) | 3.54133633 |
| 32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.52828344 |
| 33 | negative regulation of acute inflammatory response (GO:0002674) | 3.50584280 |
| 34 | hydrogen ion transmembrane transport (GO:1902600) | 3.47579962 |
| 35 | positive regulation of amino acid transport (GO:0051957) | 3.44129185 |
| 36 | synaptic vesicle maturation (GO:0016188) | 3.40996115 |
| 37 | presynaptic membrane assembly (GO:0097105) | 3.40314136 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.38960903 |
| 39 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35116264 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.30612350 |
| 41 | presynaptic membrane organization (GO:0097090) | 3.26319070 |
| 42 | behavioral defense response (GO:0002209) | 3.25985217 |
| 43 | behavioral fear response (GO:0001662) | 3.25985217 |
| 44 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.25361698 |
| 45 | neurotransmitter uptake (GO:0001504) | 3.24575584 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.23475839 |
| 47 | regulation of transmission of nerve impulse (GO:0051969) | 3.21088339 |
| 48 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.20753883 |
| 49 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.20753883 |
| 50 | neurotransmitter secretion (GO:0007269) | 3.18544598 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.17592017 |
| 52 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.16058684 |
| 53 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.13515469 |
| 54 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.12121867 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.10295366 |
| 56 | chaperone-mediated protein transport (GO:0072321) | 3.09894831 |
| 57 | proton transport (GO:0015992) | 3.09789973 |
| 58 | regulation of synaptic vesicle transport (GO:1902803) | 3.08980924 |
| 59 | hydrogen transport (GO:0006818) | 3.06062380 |
| 60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.04676868 |
| 61 | axonal fasciculation (GO:0007413) | 3.02864350 |
| 62 | response to histamine (GO:0034776) | 3.02221277 |
| 63 | locomotory exploration behavior (GO:0035641) | 3.01491876 |
| 64 | central nervous system myelination (GO:0022010) | 3.01194265 |
| 65 | axon ensheathment in central nervous system (GO:0032291) | 3.01194265 |
| 66 | positive regulation of growth hormone secretion (GO:0060124) | 2.97648222 |
| 67 | positive regulation of action potential (GO:0045760) | 2.97454762 |
| 68 | respiratory system process (GO:0003016) | 2.96457725 |
| 69 | cerebellar Purkinje cell layer development (GO:0021680) | 2.95184729 |
| 70 | fatty acid elongation (GO:0030497) | 2.94595661 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 2.94086568 |
| 72 | activation of protein kinase A activity (GO:0034199) | 2.92325894 |
| 73 | neurotransmitter transport (GO:0006836) | 2.91325001 |
| 74 | protein complex biogenesis (GO:0070271) | 2.91273306 |
| 75 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.90190915 |
| 76 | fear response (GO:0042596) | 2.88981593 |
| 77 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.85328222 |
| 78 | regulation of synapse assembly (GO:0051963) | 2.83998625 |
| 79 | neuromuscular process controlling posture (GO:0050884) | 2.81274505 |
| 80 | protein neddylation (GO:0045116) | 2.80167755 |
| 81 | sensory perception of pain (GO:0019233) | 2.79990506 |
| 82 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.77713060 |
| 83 | suckling behavior (GO:0001967) | 2.77167419 |
| 84 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.76790980 |
| 85 | synapse assembly (GO:0007416) | 2.75972569 |
| 86 | regulation of postsynaptic membrane potential (GO:0060078) | 2.75552011 |
| 87 | regulation of amino acid transport (GO:0051955) | 2.70421887 |
| 88 | multi-organism reproductive behavior (GO:0044705) | 2.69718347 |
| 89 | neurotransmitter biosynthetic process (GO:0042136) | 2.68156743 |
| 90 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.66919174 |
| 91 | neuron-neuron synaptic transmission (GO:0007270) | 2.66888179 |
| 92 | long-term memory (GO:0007616) | 2.65884860 |
| 93 | transferrin transport (GO:0033572) | 2.62863369 |
| 94 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.61922555 |
| 95 | behavioral response to cocaine (GO:0048148) | 2.61507941 |
| 96 | membrane hyperpolarization (GO:0060081) | 2.60996615 |
| 97 | regulation of vesicle fusion (GO:0031338) | 2.59986703 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58558934 |
| 99 | glutamate receptor signaling pathway (GO:0007215) | 2.58341856 |
| 100 | ferric iron transport (GO:0015682) | 2.56248502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.15284983 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.51999193 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23775517 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.18728981 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.03659660 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.93326510 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.88773314 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.80222021 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.72677502 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70219581 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.68851197 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66729574 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66729574 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65046787 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61610032 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.58618306 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57720208 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.48648094 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42748941 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.38095964 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35777231 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35315523 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.34206905 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.24726230 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.22204968 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21371249 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.18944478 |
| 28 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17722282 |
| 29 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07693368 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07436402 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07281166 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02721993 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00562424 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87269687 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.83772371 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83722172 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76218418 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69071575 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64554161 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64089412 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.63358067 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59625348 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51082113 |
| 44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50082244 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49766737 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42306730 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40508014 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39733876 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34936837 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34763653 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33132122 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33103596 |
| 53 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32487023 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29290221 |
| 55 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24014329 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22103206 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22101304 |
| 58 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20795822 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20127018 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19188789 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19125042 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19044608 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15458935 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15345618 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14654973 |
| 66 | JUN_21703547_ChIP-Seq_K562_Human | 1.12430588 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10837085 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10341127 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07295799 |
| 70 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06565545 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06519435 |
| 72 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06470963 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04843878 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00200674 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98958371 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97766419 |
| 77 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95041191 |
| 78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93615981 |
| 79 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93403855 |
| 80 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90030268 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89877769 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89020031 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88288062 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87402889 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87199364 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87072550 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85740737 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85635111 |
| 89 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85248713 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85197410 |
| 91 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85048932 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81813816 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81775673 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.78306983 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78116394 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78116394 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77613440 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77613440 |
| 99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77322725 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77204109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.99377563 |
| 2 | MP0001529_abnormal_vocalization | 4.59285862 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.02757293 |
| 4 | MP0003122_maternal_imprinting | 3.74620770 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.43116622 |
| 6 | MP0002736_abnormal_nociception_after | 3.31404733 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.18196912 |
| 8 | MP0004142_abnormal_muscle_tone | 3.07006484 |
| 9 | MP0001440_abnormal_grooming_behavior | 3.06245478 |
| 10 | MP0002064_seizures | 3.01036029 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.00171840 |
| 12 | MP0009745_abnormal_behavioral_response | 2.98103561 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.93196680 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.86536172 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.37814111 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.28777006 |
| 17 | MP0009046_muscle_twitch | 2.26647607 |
| 18 | MP0002272_abnormal_nervous_system | 2.21703350 |
| 19 | MP0004270_analgesia | 2.09132336 |
| 20 | MP0005386_behavior/neurological_phenoty | 2.03430406 |
| 21 | MP0004924_abnormal_behavior | 2.03430406 |
| 22 | MP0001502_abnormal_circadian_rhythm | 2.00905666 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.96304858 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.90789263 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.78731397 |
| 26 | MP0001486_abnormal_startle_reflex | 1.77822669 |
| 27 | MP0001905_abnormal_dopamine_level | 1.77558974 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 1.73736113 |
| 29 | MP0001970_abnormal_pain_threshold | 1.73491513 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.72819208 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.65503530 |
| 32 | MP0003283_abnormal_digestive_organ | 1.64827334 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.64787213 |
| 34 | MP0003329_amyloid_beta_deposits | 1.56817647 |
| 35 | MP0003690_abnormal_glial_cell | 1.55983071 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.55727292 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.53525120 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.51804365 |
| 39 | MP0000751_myopathy | 1.50123753 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.41467667 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.40809704 |
| 42 | MP0000778_abnormal_nervous_system | 1.39307120 |
| 43 | MP0005083_abnormal_biliary_tract | 1.36713569 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.35571861 |
| 45 | MP0003121_genomic_imprinting | 1.32302002 |
| 46 | MP0001984_abnormal_olfaction | 1.31670992 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.31153170 |
| 48 | MP0008872_abnormal_physiological_respon | 1.30041564 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.19457160 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.16192909 |
| 51 | MP0002184_abnormal_innervation | 1.15372264 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.14187086 |
| 53 | MP0003787_abnormal_imprinting | 1.12733483 |
| 54 | MP0005535_abnormal_body_temperature | 1.10144226 |
| 55 | MP0003633_abnormal_nervous_system | 1.07242761 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.05488956 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.02722105 |
| 58 | MP0000955_abnormal_spinal_cord | 1.01653708 |
| 59 | MP0003634_abnormal_glial_cell | 1.01006314 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.00290874 |
| 61 | MP0003123_paternal_imprinting | 1.00153689 |
| 62 | MP0000920_abnormal_myelination | 0.99138049 |
| 63 | MP0004811_abnormal_neuron_physiology | 0.97025239 |
| 64 | MP0002882_abnormal_neuron_morphology | 0.94363679 |
| 65 | MP0008569_lethality_at_weaning | 0.93141393 |
| 66 | MP0005310_abnormal_salivary_gland | 0.92508108 |
| 67 | MP0000604_amyloidosis | 0.91186102 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 0.89727397 |
| 69 | MP0008874_decreased_physiological_sensi | 0.89479621 |
| 70 | MP0002090_abnormal_vision | 0.89466103 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 0.89068748 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.88026777 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87464374 |
| 74 | MP0004484_altered_response_of | 0.86202413 |
| 75 | MP0003646_muscle_fatigue | 0.84568696 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.83958978 |
| 77 | MP0003631_nervous_system_phenotype | 0.81130149 |
| 78 | MP0001727_abnormal_embryo_implantation | 0.77538206 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.76552074 |
| 80 | MP0000639_abnormal_adrenal_gland | 0.75873986 |
| 81 | MP0002229_neurodegeneration | 0.74665686 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.73579727 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.73321852 |
| 84 | MP0002152_abnormal_brain_morphology | 0.73194271 |
| 85 | MP0002735_abnormal_chemical_nociception | 0.72308740 |
| 86 | MP0004885_abnormal_endolymph | 0.72179329 |
| 87 | MP0005360_urolithiasis | 0.71626100 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.68021281 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.67696474 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.67155589 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.66571914 |
| 92 | MP0001943_abnormal_respiration | 0.66280348 |
| 93 | MP0004085_abnormal_heartbeat | 0.65443137 |
| 94 | MP0004272_abnormal_basement_membrane | 0.65119905 |
| 95 | MP0003075_altered_response_to | 0.61495134 |
| 96 | MP0002163_abnormal_gland_morphology | 0.60978044 |
| 97 | MP0003959_abnormal_lean_body | 0.60823040 |
| 98 | MP0003303_peritoneal_inflammation | 0.60510942 |
| 99 | MP0004233_abnormal_muscle_weight | 0.60341286 |
| 100 | MP0001664_abnormal_digestion | 0.58753330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.01695409 |
| 2 | Abnormality of the labia minora (HP:0012880) | 5.07542745 |
| 3 | Visual hallucinations (HP:0002367) | 4.97670145 |
| 4 | Myokymia (HP:0002411) | 4.81804783 |
| 5 | Oligomenorrhea (HP:0000876) | 4.34889769 |
| 6 | Polyphagia (HP:0002591) | 4.33974760 |
| 7 | Pheochromocytoma (HP:0002666) | 4.31588995 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 4.16078516 |
| 9 | Anosmia (HP:0000458) | 4.04773183 |
| 10 | Atonic seizures (HP:0010819) | 4.00357971 |
| 11 | Abnormal pupillary function (HP:0007686) | 4.00298475 |
| 12 | Absence seizures (HP:0002121) | 3.95332511 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.92705224 |
| 14 | Abnormal eating behavior (HP:0100738) | 3.92252889 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84521449 |
| 16 | Failure to thrive in infancy (HP:0001531) | 3.80727728 |
| 17 | Hypoventilation (HP:0002791) | 3.80597467 |
| 18 | Focal seizures (HP:0007359) | 3.71784690 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.71283082 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.64130835 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.48688124 |
| 22 | Infantile muscular hypotonia (HP:0008947) | 3.42330040 |
| 23 | Dialeptic seizures (HP:0011146) | 3.41482224 |
| 24 | Acute encephalopathy (HP:0006846) | 3.39483187 |
| 25 | Hepatocellular necrosis (HP:0001404) | 3.30074983 |
| 26 | Poor suck (HP:0002033) | 3.18187487 |
| 27 | Cerebral hemorrhage (HP:0001342) | 3.14767632 |
| 28 | Narrow nasal bridge (HP:0000446) | 3.10790736 |
| 29 | Increased CSF lactate (HP:0002490) | 3.06934674 |
| 30 | Neurofibrillary tangles (HP:0002185) | 2.89825229 |
| 31 | Abnormal hair whorl (HP:0010721) | 2.87076033 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.84360916 |
| 33 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.80342561 |
| 34 | Anxiety (HP:0000739) | 2.77029978 |
| 35 | Broad metatarsal (HP:0001783) | 2.73187238 |
| 36 | Sensory axonal neuropathy (HP:0003390) | 2.72299786 |
| 37 | Psychosis (HP:0000709) | 2.58834404 |
| 38 | Generalized hypopigmentation (HP:0007513) | 2.54307785 |
| 39 | Cerebral edema (HP:0002181) | 2.53544295 |
| 40 | Sleep apnea (HP:0010535) | 2.52612917 |
| 41 | Hepatic necrosis (HP:0002605) | 2.50156037 |
| 42 | Esophageal neoplasm (HP:0100751) | 2.48545736 |
| 43 | Neoplasm of head and neck (HP:0012288) | 2.48545736 |
| 44 | Leukodystrophy (HP:0002415) | 2.48092499 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.46109492 |
| 46 | Febrile seizures (HP:0002373) | 2.42596508 |
| 47 | Esotropia (HP:0000565) | 2.41853712 |
| 48 | Parakeratosis (HP:0001036) | 2.36006083 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.34505389 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.34314247 |
| 51 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.31659860 |
| 52 | Supranuclear gaze palsy (HP:0000605) | 2.27131521 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.26028795 |
| 54 | Respiratory failure (HP:0002878) | 2.25192744 |
| 55 | Athetosis (HP:0002305) | 2.23908449 |
| 56 | Progressive inability to walk (HP:0002505) | 2.14975260 |
| 57 | Limb dystonia (HP:0002451) | 2.09879347 |
| 58 | Broad ribs (HP:0000885) | 2.09716359 |
| 59 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07887399 |
| 60 | Dysmetria (HP:0001310) | 2.00094548 |
| 61 | Amblyopia (HP:0000646) | 1.99176328 |
| 62 | Testicular neoplasm (HP:0010788) | 1.97783674 |
| 63 | Generalized hypotonia (HP:0001290) | 1.97705414 |
| 64 | Resting tremor (HP:0002322) | 1.96661197 |
| 65 | Optic disc pallor (HP:0000543) | 1.96198264 |
| 66 | Hyperventilation (HP:0002883) | 1.95249531 |
| 67 | Labial hypoplasia (HP:0000066) | 1.94827094 |
| 68 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94814496 |
| 69 | Abnormality of binocular vision (HP:0011514) | 1.94799811 |
| 70 | Diplopia (HP:0000651) | 1.94799811 |
| 71 | Rapidly progressive (HP:0003678) | 1.94274648 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91488400 |
| 73 | Impaired pain sensation (HP:0007328) | 1.90820865 |
| 74 | Abnormality of pain sensation (HP:0010832) | 1.90820865 |
| 75 | Papilledema (HP:0001085) | 1.90307242 |
| 76 | CNS hypomyelination (HP:0003429) | 1.90244527 |
| 77 | Fair hair (HP:0002286) | 1.88247824 |
| 78 | Myotonia (HP:0002486) | 1.87620722 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.84428366 |
| 80 | Depression (HP:0000716) | 1.84081766 |
| 81 | Mutism (HP:0002300) | 1.82753123 |
| 82 | Agitation (HP:0000713) | 1.81606879 |
| 83 | Hip dysplasia (HP:0001385) | 1.78382967 |
| 84 | Rimmed vacuoles (HP:0003805) | 1.78325312 |
| 85 | Bradykinesia (HP:0002067) | 1.78116116 |
| 86 | Postural tremor (HP:0002174) | 1.77903467 |
| 87 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76727341 |
| 88 | X-linked dominant inheritance (HP:0001423) | 1.76464722 |
| 89 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74194436 |
| 90 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.71494312 |
| 91 | Progressive cerebellar ataxia (HP:0002073) | 1.71302294 |
| 92 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.70642090 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70642090 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 1.70642090 |
| 95 | Shoulder girdle muscle weakness (HP:0003547) | 1.69651697 |
| 96 | Truncal ataxia (HP:0002078) | 1.68173928 |
| 97 | Scanning speech (HP:0002168) | 1.67768683 |
| 98 | Postural instability (HP:0002172) | 1.66931500 |
| 99 | Split foot (HP:0001839) | 1.66888608 |
| 100 | Rigidity (HP:0002063) | 1.65847349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.49088269 |
| 2 | MARK1 | 4.41919176 |
| 3 | MAP3K12 | 3.73485940 |
| 4 | GRK7 | 3.38507165 |
| 5 | MAP3K4 | 3.02809200 |
| 6 | MAP2K4 | 2.86040291 |
| 7 | PNCK | 2.64425873 |
| 8 | EPHA4 | 2.49626059 |
| 9 | CDK19 | 2.48230407 |
| 10 | NME1 | 2.42374726 |
| 11 | MAP3K9 | 2.11524373 |
| 12 | MINK1 | 2.03331265 |
| 13 | OXSR1 | 1.86952984 |
| 14 | NTRK1 | 1.84938314 |
| 15 | MAP2K7 | 1.80999297 |
| 16 | FES | 1.68154415 |
| 17 | NTRK2 | 1.60691177 |
| 18 | RIPK4 | 1.58565593 |
| 19 | CASK | 1.57410372 |
| 20 | ARAF | 1.34273637 |
| 21 | CDK5 | 1.33828693 |
| 22 | PLK2 | 1.33347897 |
| 23 | UHMK1 | 1.33062346 |
| 24 | ERBB3 | 1.28121359 |
| 25 | ADRBK1 | 1.27155362 |
| 26 | GRK5 | 1.25114136 |
| 27 | PRKCG | 1.22467888 |
| 28 | MAPK13 | 1.21676240 |
| 29 | CAMK2A | 1.20729727 |
| 30 | PAK6 | 1.20708060 |
| 31 | PAK3 | 1.19779481 |
| 32 | PIK3CG | 1.16390586 |
| 33 | IRAK1 | 1.03969494 |
| 34 | GRK6 | 0.98388110 |
| 35 | PHKG2 | 0.97855743 |
| 36 | PHKG1 | 0.97855743 |
| 37 | LATS2 | 0.97029915 |
| 38 | KSR2 | 0.94871611 |
| 39 | CAMK2G | 0.91930865 |
| 40 | CAMKK1 | 0.91058007 |
| 41 | CAMK2B | 0.90207812 |
| 42 | CSNK1G3 | 0.89906042 |
| 43 | FER | 0.89403187 |
| 44 | ABL2 | 0.86785580 |
| 45 | PRKCE | 0.86343522 |
| 46 | DAPK2 | 0.86274895 |
| 47 | CDK14 | 0.84376208 |
| 48 | CDK18 | 0.83700125 |
| 49 | CAMKK2 | 0.83351614 |
| 50 | CSNK1G2 | 0.83345661 |
| 51 | MAPKAPK5 | 0.83144606 |
| 52 | CDK15 | 0.82552361 |
| 53 | SCYL2 | 0.80289266 |
| 54 | STK11 | 0.79667178 |
| 55 | PRKCH | 0.79086881 |
| 56 | CAMK2D | 0.75508703 |
| 57 | BMPR2 | 0.74037103 |
| 58 | MYLK | 0.72740825 |
| 59 | TNK2 | 0.70682480 |
| 60 | CDK11A | 0.67236258 |
| 61 | PTK2B | 0.65104334 |
| 62 | MARK2 | 0.64983491 |
| 63 | CAMK1G | 0.64936574 |
| 64 | EPHB1 | 0.64697285 |
| 65 | BCR | 0.63095893 |
| 66 | TESK2 | 0.61755796 |
| 67 | FYN | 0.61597761 |
| 68 | ROCK2 | 0.61564579 |
| 69 | LMTK2 | 0.61324049 |
| 70 | DDR2 | 0.57675598 |
| 71 | MAP3K13 | 0.53490358 |
| 72 | RET | 0.52468508 |
| 73 | CAMK1 | 0.51917490 |
| 74 | FGR | 0.51540066 |
| 75 | ALK | 0.51391288 |
| 76 | SGK223 | 0.50764412 |
| 77 | SGK494 | 0.50764412 |
| 78 | PRKACA | 0.49505023 |
| 79 | EGFR | 0.48409288 |
| 80 | MAPK4 | 0.47276299 |
| 81 | PRKCZ | 0.45579621 |
| 82 | PRKD3 | 0.45462111 |
| 83 | PRKCB | 0.44033540 |
| 84 | SRC | 0.43905659 |
| 85 | STK39 | 0.43022077 |
| 86 | LIMK1 | 0.42841350 |
| 87 | DAPK3 | 0.42447183 |
| 88 | CSNK1E | 0.41699828 |
| 89 | FGFR2 | 0.41546433 |
| 90 | TNIK | 0.39780339 |
| 91 | CSNK1A1L | 0.39632987 |
| 92 | PRKCQ | 0.39304031 |
| 93 | PRKACG | 0.37613485 |
| 94 | MAP3K11 | 0.36761430 |
| 95 | PRKCA | 0.36682643 |
| 96 | DAPK1 | 0.36273451 |
| 97 | PDPK1 | 0.36143403 |
| 98 | CSNK1G1 | 0.35947920 |
| 99 | MAPK10 | 0.35874120 |
| 100 | MOS | 0.35706351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.15988562 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.42187228 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.40033209 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 2.94354997 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.77430711 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.67225304 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.65395610 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.62077548 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.60744980 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.42231096 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09713913 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 1.91377273 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88458827 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78349839 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.77639364 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75738287 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73716578 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.71533303 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.69384286 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.62648850 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55471496 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.53568726 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52331159 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50566640 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.43764003 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.36475232 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35110630 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.34761793 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.23491851 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21615944 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19919333 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18505237 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.14431568 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11036947 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10438751 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10195281 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07563745 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05183629 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02205476 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01912455 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94214809 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.92935016 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 0.91394479 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91366378 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91130351 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91007094 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90595596 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85766418 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85050988 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84387656 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82713535 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79030419 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76290765 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.75381560 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74539057 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.72064832 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69458760 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69307278 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.69110789 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61602547 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.59467402 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59410608 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50400801 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49494607 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48920406 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.46520523 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44504048 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43677450 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43458980 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.39827460 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39498215 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38754609 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.38560651 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35782757 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34696222 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33909028 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33589196 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.32734466 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.31854522 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29551882 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.29340426 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29312382 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28740459 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28270871 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25452200 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25156986 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24027949 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23347371 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22879383 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22181457 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21186996 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20223039 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17784984 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17182737 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16678269 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16558723 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.16258012 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.15770674 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14745500 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.14058973 |

